13D/13G Filings - Cormorant Asset Management LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, ...6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-02-14
3:01 pm
Sale
2023-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 0
0.000%
-5,150,000decrease
(Position Closed)
Filing
History
2024-02-14
3:01 pm
Sale
2023-12-31 13G Cabaletta Bio, Inc.
CABA
Cormorant Asset Management LP 0
0.000%
-1,971,739decrease
(Position Closed)
Filing
History
2024-02-14
3:00 pm
Sale
2023-12-31 13G Astria Therapeutics, Inc.
ATXS
Cormorant Asset Management LP 0
0.000%
-1,650,000decrease
(Position Closed)
Filing
History
2024-02-14
3:00 pm
Sale
2023-12-19 13G 89bio, Inc.
ETNB
Cormorant Asset Management LP 0
0.000%
-2,550,000decrease
(Position Closed)
Filing
History
2024-01-30
4:41 pm
Sale
2023-11-29 13D Erasca, Inc.
ERAS
Cormorant Asset Management LP 0
0.000%
-10,893,107decrease
(Position Closed)
Filing
History
2023-12-14
4:04 pm
Purchase
2023-12-04 13G EyePoint Pharmaceuticals, Inc.
EYPT
Cormorant Asset Management LP 6,038,235
12.360%
6,038,235increase
(New Position)
Filing
History
2023-11-16
4:02 pm
Purchase
2023-11-06 13G Korro Bio, Inc.
KRRO
Cormorant Asset Management LP 679,170
8.490%
679,170increase
(New Position)
Filing
History
2023-11-13
4:03 pm
Purchase
2023-11-01 13G VYNE Therapeutics Inc.
VYNE
Cormorant Asset Management LP 1,394,336
9.990%
1,394,336increase
(New Position)
Filing
History
2023-11-06
4:01 pm
Purchase
2023-10-25 13G Harpoon Therapeutics, Inc.
HARP
Cormorant Asset Management LP 1,678,619
9.900%
1,678,619increase
(New Position)
Filing
History
2023-10-23
4:02 pm
Purchase
2023-10-11 13G Alpine Immune Sciences, Inc.
ALPN
Cormorant Asset Management LP 2,850,000
5.790%
2,850,000increase
(New Position)
Filing
History
2023-10-13
4:00 pm
Purchase
2023-10-03 13G ALX Oncology Holdings Inc.
ALXO
Cormorant Asset Management LP 3,142,079
6.310%
3,142,079increase
(New Position)
Filing
History
2023-10-10
4:01 pm
Purchase
2023-09-29 13G Marinus Pharmaceuticals, Inc.
MRNS
Cormorant Asset Management LP 2,800,000
5.530%
2,800,000increase
(New Position)
Filing
History
2023-04-24
5:26 pm
Purchase
2023-04-20 13G Immuneering Corporation
IMRX
Cormorant Asset Management LP 4,204,364
14.420%
1,918,183increase
(+83.90%)
Filing
History
2023-03-13
4:00 pm
Purchase
2023-03-03 13G Ambrx Biopharma Inc.
AMAM
Cormorant Asset Management LP 52,500,000
17.730%
36,145,298increase
(+221.01%)
Filing
History
2023-02-14
3:15 pm
Sale
2022-12-31 13G Elevation Oncology, Inc.
ELEV
Cormorant Asset Management LP 1,952,032
8.380%
-31,136decrease
(-1.57%)
Filing
History
2023-02-14
3:14 pm
Sale
2022-12-31 13G Constellation Pharmaceuticals, Inc.
CNST
Cormorant Asset Management LP 5,150,000
9.210%
-290,451decrease
(-5.34%)
Filing
History
2023-02-14
3:13 pm
Sale
2022-12-31 13G GreenLight Biosciences Holdings
GRNA
Cormorant Asset Management LP 9,188,659
6.060%
-290,399decrease
(-3.06%)
Filing
History
2023-02-14
3:13 pm
Purchase
2022-12-31 13G Immuneering Corporation
IMRX
Cormorant Asset Management LP 2,286,181
8.660%
33,553increase
(+1.49%)
Filing
History
2023-02-14
3:12 pm
Sale
2022-12-31 13G Ambrx Biopharma Inc.
AMAM
Cormorant Asset Management LP 16,354,702
6.050%
-911,442decrease
(-5.28%)
Filing
History
2023-02-14
3:11 pm
Sale
2022-12-31 13G Monte Rosa Therapeutics, Inc.
GLUE
Cormorant Asset Management LP 2,893,717
5.980%
-108,483decrease
(-3.61%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, ...6, 7, Next